Author

Praveen Kumar Chandra Sekar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Oncogenic Signalling and Immune Checkpoint Crosstalk in Cancer: Emerging Targets and Precision Therapeutic Strategies.

INTRODUCTION Cancer progression is sustained by complex interactions between oncogenic signaling pathways and immune checkpoint networks, yet their mechanistic crosstalk remains poorly integrated in existing reviews. This review synthesises the bidirectional regulatory relationships between oncogenic signaling and immu...

Praveen Kumar Chandra Sekar, R. Veerabathiran · Current Drug Targets · 0 citations

Review Open access Jun 2026

Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with Increased Susceptibility to Vasculitis: A Systematic Review and Meta-Analysis

Objective: This meta-analysis aimed to evaluate the association between the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism and susceptibility to vasculitis, including Henoch– Schönlein purpura (HSP), Henoch–Schönlein purpura nephritis (HSPN), and Behçet’s disease (BD). Methods: Relevant studi...

Praveen Kumar Chandra Sekar, R. Veerabathiran · Mediterranean Journal of Rhe... · 0 citations